Details of the Drug

General Information of Drug (ID: DMF7HVU)

Drug Name

Isatuximab

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Approved	[1]
Plasma cell myeloma	2A83.1	Phase 3	[2]
------------------------------------------------------------------------------------

Affected Organisms

Humans and other mammals

ATC Code

L01FC02: Isatuximab

L01FC: CD38 (Clusters of Differentiation 38) inhibitors

L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

L01: ANTINEOPLASTIC AGENTS

L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Cross-matching ID

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2	ClinicalTrials.gov (NCT04270409) Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma. U.S. National Institutes of Health.